A neuroimaging biomarker for striatal dysfunction in schizophrenia

Journal: Nature Medicine

Published: 2020-03-23

DOI: 10.1038/s41591-020-0793-8

Affiliations: 30

Authors: 40

Go to article
Institutions Share
School of Artificial Intelligence, UCAS, China 0.09
Brainnetome Center, IA CAS, China 0.08
National Laboratory of Pattern Recognition, IA CAS, China 0.08
First Affiliated Hospital, KMU, China 0.08
Zhumadian City Psychiatric Hospital, China 0.08
Xijing Hospital, China 0.08
CAS Center for Excellence in Brain Science and Intelligence Technology (CEBSIT), China 0.06
Institute of Mental Health (IMH), PUHSC PKU, China 0.06
MOH Key Laboratory of Mental Health, PUHSC PKU, China 0.06
National Clinical Research Center for Mental Disorders, PUHSC PKU, China 0.06
Guangzhou Brain Hospital, China 0.05
Renmin Hospital of Wuhan University/Hubei General Hospital, China 0.05
Henan Key Laboratory of Biological Psychiatry, XXMU, China 0.03
Second Affiliated Hospital of Xinxiang Medical University, China 0.03
School of Computer and Information Technology (School of Big Data), SXU, China 0.03
Department of Psychiatry, University of Cambridge, United Kingdom (UK) 0.01
Melbourne Neuropsychiatry Centre (MNC), Australia 0.01
Alan Turing Institute, United Kingdom (UK) 0.01
Department of Biomedical Engineering (BME), UniMelb, Australia 0.01
Artificial Intelligence Research (AIR), CAS, China 0.01
School of Psychology, XXMU, China 0.01
MRC London Institute of Medical Sciences (LMS), United Kingdom (UK) 0.01
Hammersmith Hospital, Imperial College Healthcare NHS Trust, United Kingdom (UK) 0.01
Institute of Psychiatry, Psychology and Neuroscience (IOPPN), KCL, United Kingdom (UK) 0.01
State Key Laboratory of Brain and Cognitive Sciences, IBP CAS, China 0.01
Center for Life Sciences (CLS), PKU, China 0.01
IDG/McGovern Institute for Brain Research, PKU, China 0.01
MOE Key Laboratory for NeuroInformation, UESTC, China 0
Queensland Brain Institute (QBI), UQ, Australia 0

Return